The Regulatory Effects of Purα on PARP1 Gene Expression and its functions on DNA repair
Abstract
Abstract: The luciferase reporter construct, which contains a poly ADP-ribose polymerase 1 gene promoter, was transfected into U87MG cells with the Purα eukaryotic expression vector, and the activities of PARP1 promoter were assessed by luciferase assay to evaluate the regulatory effects of Purα on PARP1 gene expression. The Purα eukaryotic expression vector was transfected into U87MG cells, and the cell total RNA and protein were extracted to determine the effects of Purα on PARP1 gene expression at transcriptional and translational levels by real-time PCR and Western blotting assay. The results demonstrated that Purα can positively regulate PARP1 promoter activity and promote PARP1 gene expression both at transcriptional and translational levels. The further study illustrated that Purα can collaborate with PARP1 in the repair of damaged DNA; the results of a pull-down assay suggested that there is a physical interaction between Purα and PARP1. The overexpression of Purα can increase endogenous PARP1 expression and alleviate the expression of the DNA damage signal protein γH2AX. Above all, we believe that Purα possesses a positive regulatory effect on PARP1 gene expression and collaborates with PARP1 to repair damaged DNA.
Keywords: Purα; poly ADP-ribose polymerase 1; regulation of gene expression, DNA damage, and repair.
References
2 Chapman JR, Taylor MR, Boulton SJ. Playing the end game: DNA double-strand break repair pathway choice. Molecular cell 2012; 47 (4): 497-510.
3 Wilusz CJ, Wilusz J. HuR and translation--the missing linc(RNA). Molecular cell 2012; 47 (4): 495-6.
4 Hsu CF, Tseng HC, Chiu CF, Liang SY, Tsai CW, Tsai MH, et al. Association between DNA double strand break gene Ku80 polymorphisms and oral cancer susceptibility. Oral oncology 2009; 45 (9): 789-93.
5 Liu Y, Shete S, Wang LE, El-Zein R, Etzel CJ, Liang FW, et al. Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk. Carcinogenesis 2010; 31 (10): 1762-9.
6 Li R, Yang Y, An Y, Zhou Y, Liu Y, Yu Q, et al. Genetic polymorphisms in DNA double-strand break repair genes XRCC5, XRCC6 and susceptibility to hepatocellular carcinoma. Carcinogenesis 2011; 32 (4): 530-6.
7 Wang J, Zhao Y, Jiang J, Gajalakshmi V, Kuriki K, Nakamura S, et al. Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population. Journal of cancer research and clinical oncology 2010; 136 (10): 1517-25.
8 Kwei KA, Kung Y, Salari K, Holcomb IN, Pollack JR. Genomic instability in breast cancer: pathogenesis and clinical implications. Molecular oncology 2010; 4 (3): 255-66.
9 Ame JC, Spenlehauer C, de Murcia G. The PARP superfamily. BioEssays : news and reviews in molecular, cellular and developmental biology 2004; 26 (8): 882-93.
10 Sidorkina O, Espey MG, Miranda KM, Wink DA, Laval J. Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species. Free radical biology & medicine 2003; 35 (11): 1431-8.
11 Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. PARP inhibition: PARP1 and beyond. Nature reviews Cancer 2010; 10 (4): 293-301.
12 Audeh MW, Carmichael J, Penson RT, Friedlander M, Powell B, Bell-McGuinn KM, et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet 2010; 376 (9737): 245-51.
13 Michels J, Vitale I, Saparbaev M, Castedo M, Kroemer G. Predictive biomarkers for cancer therapy with PARP inhibitors. Oncogene 2014; 33 (30): 3894-907.
14 Haas S, Gordon J, Khalili K. A developmentally regulated DNA-binding protein from mouse brain stimulates myelin basic protein gene expression. Molecular and cellular biology 1993; 13 (5): 3103-12.
15 Haas S, Thatikunta P, Steplewski A, Johnson EM, Khalili K, Amini S. A 39-kD DNA-binding protein from mouse brain stimulates transcription of myelin basic protein gene in oligodendrocytic cells. J Cell Biol 1995; 130 (5): 1171-9.
16 Bergemann AD, Ma ZW, Johnson EM. Sequence of cDNA comprising the human pur gene and sequence-specific single-stranded-DNA-binding properties of the encoded protein. Molecular and cellular biology 1992; 12 (12): 5673-82.
17 Ma ZW, Bergemann AD, Johnson EM. Conservation in human and mouse Pur alpha of a motif common to several proteins involved in initiation of DNA replication. Gene 1994; 149 (2): 311-4.
18 Liu H, Johnson EM. Distinct proteins encoded by alternative transcripts of the PURG gene, located contrapodal to WRN on chromosome 8, determined by differential termination/polyadenylation. Nucleic acids research 2002; 30 (11): 2417-26.
19 Moore GL, Maranas CD. eCodonOpt: a systematic computational framework for optimizing codon usage in directed evolution experiments. Nucleic acids research 2002; 30 (11): 2407-16.
20 Wang H, White MK, Kaminski R, Darbinian N, Amini S, Johnson EM, et al. Role of Puralpha in the modulation of homologous recombination-directed DNA repair by HIV-1 Tat. Anticancer research 2008; 28 (3A): 1441-7.
21 White MK, Johnson EM, Khalili K. Multiple roles for Puralpha in cellular and viral regulation. Cell cycle 2009; 8 (3): 1-7.
22 Hegan DC, Lu Y, Stachelek GC, Crosby ME, Bindra RS, Glazer PM. Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130. Proceedings of the National Academy of Sciences of the United States of America 2010; 107 (5): 2201-6.
23 Patel AG, Sarkaria JN, Kaufmann SH. Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells. Proceedings of the National Academy of Sciences of the United States of America 2011; 108 (8): 3406-11.
24 Strom CE, Johansson F, Uhlen M, Szigyarto CA, Erixon K, Helleday T. Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate. Nucleic acids research 2011; 39 (8): 3166-75.
25 Kim EH, Min HY, Chung HJ, Song J, Park HJ, Kim S, et al. Anti-proliferative activity and suppression of P-glycoprotein by (-)-antofine, a natural phenanthroindolizidine alkaloid, in paclitaxel-resistant human lung cancer cells. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2012; 50 (3-4): 1060-5.
26 Tretiakova A, Steplewski A, Johnson EM, Khalili K, Amini S. Regulation of myelin basic protein gene transcription by Sp1 and Puralpha: evidence for association of Sp1 and Puralpha in brain. Journal of cellular physiology 1999; 181 (1): 160-8.
27 Wei Q, Miskimins WK, Miskimins R. Stage-specific expression of myelin basic protein in oligodendrocytes involves Nkx2.2-mediated repression that is relieved by the Sp1 transcription factor. The Journal of biological chemistry 2005; 280 (16): 16284-94.
28 Kong T, Scully M, Shelley CS, Colgan SP. Identification of Pur alpha as a new hypoxia response factor responsible for coordinated induction of the beta 2 integrin family. Journal of immunology 2007; 179 (3): 1934-41.
29 Limesand SW, Jeckel KM, Anthony RV. Puralpha, a single-stranded deoxyribonucleic acid binding protein, augments placental lactogen gene transcription. Molecular endocrinology 2004; 18 (2): 447-57.
30 Shelley CS, Teodoridis JM, Park H, Farokhzad OC, Bottinger EP, Arnaout MA. During differentiation of the monocytic cell line U937, Pur alpha mediates induction of the CD11c beta 2 integrin gene promoter. Journal of immunology 2002; 168 (8): 3887-93.
31 Lalani SR, Zhang J, Schaaf CP, Brown CW, Magoulas P, Tsai AC, et al. Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome. American journal of human genetics 2014; 95 (5): 579-83.
32 Hunt D, Leventer RJ, Simons C, Taft R, Swoboda KJ, Gawne-Cain M, et al. Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability. Journal of medical genetics 2014; 51 (12): 806-13.
33 Hotz HR, Biebinger S, Flaspohler J, Clayton C. PARP gene expression: control at many levels. Molecular and biochemical parasitology 1998; 91 (1): 131-43.
34 Zhu H, Jiang Z, Lei P, Huang W, Yu X. Poly(ADP-ribose) polymerase-1 mediates angiotensin II-induced expression of plasminogen activator inhibitor-1 and fibronectin in rat mesangial cells. Kidney & blood pressure research 2011; 34 (5): 320-7.
Copyright (c) 2020 Journal of Internal Medicine: Science & Art
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.